Latest Articles

Publication Date
Metri Bio Raises $5M in Pre-Seed Funding - FinSMEs

Metri Bio Raises $5M in Pre-Seed Funding FinSMEs

Published: Dec. 2, 2025, 1:01 p.m.
Funding needed for Women's Health Hub in Hartlepool to continue services - hellorayo.co.uk

Funding needed for Women's Health Hub in Hartlepool to continue services hellorayo.co.uk

Published: Nov. 19, 2025, 5:37 p.m.
Western Australia backs 12 medtech startup ideas with $5 million in Seed funding - Startup Daily

Western Australia backs 12 medtech startup ideas with $5 million in Seed funding Startup Daily

Published: Nov. 19, 2025, 5:56 a.m.
Merck secures $700 million funding from Blackstone to develop cancer therapy - ETPharma.com

Merck secures $700 million funding from Blackstone to develop cancer therapy ETPharma.com

Published: Nov. 5, 2025, 12:32 p.m.
Merck secures $700 million funding from Blackstone to develop cancer therapy - ET Pharma

Merck secures $700 million funding from Blackstone to develop cancer therapy ET Pharma

Published: Nov. 5, 2025, 12:32 p.m.
CORRECTING and REPLACING Faeth Therapeutics' $92 Million Total Funding Powers PIKTOR Phase 2 Following 80% Response Rate in Endometrial Cancer - BioSpace

CORRECTING and REPLACING Faeth Therapeutics' $92 Million Total Funding Powers PIKTOR Phase 2 Following 80% Response Rate in Endometrial Cancer BioSpace

Published: Oct. 28, 2025, 5:03 a.m.
Cyclana Bio Secures £5 Million Pre-Seed Funding to Advance Endometriosis Drug Discovery - Global Legal Chronicle

Cyclana Bio Secures £5 Million Pre-Seed Funding to Advance Endometriosis Drug Discovery Global Legal Chronicle

Published: Oct. 28, 2025, midnight
CORRECTING and REPLACING Faeth Therapeutics' $92 Million Total Funding Powers PIKTOR Phase 2 Following 80% Response Rate in Endometrial Cancer - The AI Journal

CORRECTING and REPLACING Faeth Therapeutics' $92 Million Total Funding Powers PIKTOR Phase 2 Following 80% Response Rate in Endometrial Cancer The AI Journal

Published: Oct. 27, 2025, 7:50 p.m.
CORRECTING and REPLACING Faeth Therapeutics' $92 Million Total Funding Powers PIKTOR Phase 2 Following 80% Response Rate in Endometrial Cancer - Yahoo Finance

CORRECTING and REPLACING Faeth Therapeutics' $92 Million Total Funding Powers PIKTOR Phase 2 Following 80% Response Rate in Endometrial Cancer Yahoo Finance

Published: Oct. 27, 2025, 7:33 p.m.
CORRECTING and REPLACING Faeth Therapeutics' $92 Million Total Funding Powers PIKTOR Phase 2 Following 80% Response Rate in Endometrial Cancer - Business Wire

CORRECTING and REPLACING Faeth Therapeutics' $92 Million Total Funding Powers PIKTOR Phase 2 Following 80% Response Rate in Endometrial Cancer Business Wire

Published: Oct. 27, 2025, 7:33 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!